Phosphoproteomics of fibroblast growth factor 1 (FGF1) signaling in chondrocytes: Identifying the signature of inhibitory response

Jessica R. Chapman, Olga Katsara, Rachel Ruoff, David Morgenstern, Shruti Nayak, Claudio Basilico, Beatrix Ueberheide, Victoria Kolupaeva

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Abstract

Fibroblast growth factor (FGF) signaling is vital for many biological processes, beginning with development. The importance of FGF signaling for skeleton formation was first discovered by the analysis of genetic FGFR mutations which cause several bone morphogenetic disorders, including achondroplasia, the most common form of human dwarfism. The formation of the long bones is mediated through proliferation and differentiation of highly specialized cells-chondrocytes. Chondrocytes respond to FGF with growth inhibition, a unique response which differs from the proliferative response of the majority of cell types; however, its molecular determinants are still unclear. Quantitative phosphoproteomic analysis was utilized to catalogue the proteins whose phosphorylation status is changed upon FGF1 treatment. The generated dataset consists of 756 proteins. We could localize the divergence between proliferative (canonical) and inhibitory (chondrocyte specific) FGF transduction pathways immediately upstream of AKT kinase. Gene Ontology (GO) analysis of the FGF1 regulated peptides revealed that many of the identified phosphorylated proteins are assigned to negative regulation clusters, in accordance with the observed inhibitory growth response. This is the first time a comprehensive subset of proteins involved in FGF inhibitory response is defined. We were able to identify a number of targets and specifically discover glycogen synthase kinase3β (GSK3β) as a novel key mediator of FGF inhibitory response in chondrocytes.

Original languageEnglish
Pages (from-to)1126-1137
Number of pages12
JournalMolecular & Cellular Proteomics
Volume16
Issue number6
DOIs
Publication statusPublished - Jun 2017

Funding

NIH [AR063128]; NIH/ORIP [S10OD010582]This work was supported by NIH grant AR063128 (to V.K.) and with a Shared Instrumentation Grant from the NIH/ORIP S10OD010582 for the purchase of an Orbitrap Fusion mass spectrometer. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was supported by NIH grant AR063128 (to V.K.) and with a Shared Instrumentation Grant from the NIH/ORIP S10OD010582 for the purchase of an Orbitrap Fusion mass spectrometer. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

All Science Journal Classification (ASJC) codes

  • Analytical Chemistry
  • Biochemistry
  • Molecular Biology

Fingerprint

Dive into the research topics of 'Phosphoproteomics of fibroblast growth factor 1 (FGF1) signaling in chondrocytes: Identifying the signature of inhibitory response'. Together they form a unique fingerprint.

Cite this